Diet study for mild-to-moderate psoriasis in adults
Part of Digestive system, Hormones & metabolism, Skin clinical trials.
This trial studies whether a dietary approach can help people with mild-to-moderate psoriasis. It may be especially focused on people who do not have signs of wheat/gluten-related immune reactions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 64 years old
- Have mild-to-moderate psoriasis, not severe plaque psoriasis
- Not use psoriasis medicines that affect the whole body for at least 3 months
- Blood tests must be negative for certain wheat/gluten-related antibodies (anti-DGP, anti-tTG, and EmA)
- You must test negative for wheat/gluten allergy (negative prick test and/or wheat/gluten blood IgE tests)
- You must not be pregnant, and must not have certain infections, bowel disease, cancer, or major health problems that affect digestion or daily activity
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding a gluten-free, low-histamine anti-inflammatory diet, and in some cases physical therapy, helps children with mild-to-moderate plaque psoriasis. It aims to see if these lifestyle changes can improve skin symptoms when combined with usual treatment.
This study looks at how the immune system of children with celiac disease responds to a small amount of gluten. It may help researchers understand the disease better and find new ways to monitor it.
This study uses a full-body PET scan to see if switching to a balanced, nutritious diet can lower inflammation throughout the body and in the skin for people with psoriasis. It may help if you are overweight and have a poor diet.
This study looks at how your immune system responds when you eat gluten, including for people with celiac disease. You may be asked to follow a gluten-free diet first and then safely reintroduce gluten so researchers can measure immune changes.
This trial studies how guselkumab works for people with long-lasting, more severe psoriasis and signs that may affect joints. It may help by improving psoriasis symptoms and possibly reducing related inflammation, while researchers track safety and outcomes.
This study looks at how blood sugar control (including diabetes) changes immune cells in the skin for people with moderate to severe plaque psoriasis. It may help researchers understand what drives psoriasis and how it could respond to future treatments.
Hear when a new Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.